Final  ||| S:0 E:6 ||| JJ
amended  ||| S:6 E:14 ||| JJ
report  ||| S:14 E:21 ||| NN
on  ||| S:21 E:24 ||| IN
safety  ||| S:24 E:31 ||| NN
assessment  ||| S:31 E:42 ||| NN
on  ||| S:42 E:45 ||| IN
aminomethyl  ||| S:45 E:57 ||| JJ
propanol  ||| S:57 E:66 ||| NN
and  ||| S:66 E:70 ||| CC
aminomethyl  ||| S:70 E:82 ||| FW
propanediol  ||| S:82 E:94 ||| FW
Aminomethyl  ||| S:94 E:106 ||| FW
propanol  ||| S:106 E:115 ||| FW
and  ||| S:115 E:119 ||| CC
aminomethyl  ||| S:119 E:131 ||| JJ
propanediol  ||| S:131 E:143 ||| NNS
are  ||| S:143 E:147 ||| VBP
substituted  ||| S:147 E:159 ||| VBN
aliphatic  ||| S:159 E:169 ||| JJ
alcohols  ||| S:169 E:178 ||| NN
that  ||| S:178 E:183 ||| IN
function  ||| S:183 E:192 ||| NN
as  ||| S:192 E:195 ||| IN
pH  ||| S:195 E:198 ||| JJ
adjusters  ||| S:198 E:208 ||| NNS
in  ||| S:208 E:211 ||| IN
cosmetic  ||| S:211 E:220 ||| JJ
products  ||| S:220 E:229 ||| NNS
at  ||| S:229 E:232 ||| IN
concentrations  ||| S:232 E:247 ||| NNS
less  ||| S:247 E:252 ||| RBR
than  ||| S:252 E:257 ||| IN
10 ||| S:257 E:259 ||| CD
% ||| S:259 E:260 ||| NN
;  ||| S:260 E:262 ||| :
additionally ||| S:262 E:274 ||| RB
,  ||| S:274 E:276 ||| ,
aminomethyl  ||| S:276 E:288 ||| JJ
propanediol  ||| S:288 E:300 ||| NN
is  ||| S:300 E:303 ||| VBZ
a  ||| S:303 E:305 ||| DT
fragrance ||| S:305 E:314 ||| NN
.  ||| S:314 E:316 ||| .
Extensive  ||| S:316 E:326 ||| JJ
oral  ||| S:326 E:331 ||| JJ
toxicity  ||| S:331 E:340 ||| NN
data  ||| S:340 E:345 ||| NNS
are  ||| S:345 E:349 ||| VBP
reviewed ||| S:349 E:357 ||| VBN
,  ||| S:357 E:359 ||| ,
with  ||| S:359 E:364 ||| IN
fewer  ||| S:364 E:370 ||| JJR
inhalation  ||| S:370 E:381 ||| JJ
toxicity  ||| S:381 E:390 ||| NN
data ||| S:390 E:394 ||| NNS
.  ||| S:394 E:396 ||| .
Dermal  ||| S:396 E:403 ||| JJ
toxicity  ||| S:403 E:412 ||| NN
data  ||| S:412 E:417 ||| NNS
are  ||| S:417 E:421 ||| VBP
presented  ||| S:421 E:431 ||| VBN
that  ||| S:431 E:436 ||| IN
demonstrate ||| S:436 E:447 ||| NN
,  ||| S:447 E:449 ||| ,
for  ||| S:449 E:453 ||| IN
example ||| S:453 E:460 ||| NN
,  ||| S:460 E:462 ||| ,
that  ||| S:462 E:467 ||| IN
a  ||| S:467 E:469 ||| DT
mascara  ||| S:469 E:477 ||| NN
with  ||| S:477 E:482 ||| IN
1.92 ||| S:482 E:486 ||| CD
%  ||| S:486 E:488 ||| NN
aminomethyl  ||| S:488 E:500 ||| NN
propanediol  ||| S:500 E:512 ||| NN
does  ||| S:512 E:517 ||| VBZ
not  ||| S:517 E:521 ||| RB
cause  ||| S:521 E:527 ||| VB
dermal  ||| S:527 E:534 ||| JJ
irritation  ||| S:534 E:545 ||| NN
or  ||| S:545 E:548 ||| CC
allergic  ||| S:548 E:557 ||| JJ
contact  ||| S:557 E:565 ||| NN
sensitization ||| S:565 E:578 ||| NN
,  ||| S:578 E:580 ||| ,
suggesting  ||| S:580 E:591 ||| VBG
that  ||| S:591 E:596 ||| IN
the  ||| S:596 E:600 ||| DT
maximum  ||| S:600 E:608 ||| NN
reported  ||| S:608 E:617 ||| VBD
use  ||| S:617 E:621 ||| NN
concentration  ||| S:621 E:635 ||| NN
of  ||| S:635 E:638 ||| IN
2 ||| S:638 E:639 ||| CD
%  ||| S:639 E:641 ||| NN
in  ||| S:641 E:644 ||| IN
mascara  ||| S:644 E:652 ||| NN
would  ||| S:652 E:658 ||| MD
be  ||| S:658 E:661 ||| VB
safe ||| S:661 E:665 ||| JJ
.  ||| S:665 E:667 ||| .
Although  ||| S:667 E:676 ||| IN
these  ||| S:676 E:682 ||| DT
ingredients  ||| S:682 E:694 ||| NNS
are  ||| S:694 E:698 ||| VBP
primary  ||| S:698 E:706 ||| JJ
amines  ||| S:706 E:713 ||| NN
that  ||| S:713 E:718 ||| WDT
are  ||| S:718 E:722 ||| VBP
not  ||| S:722 E:726 ||| RB
substrates  ||| S:726 E:737 ||| VBN
for  ||| S:737 E:741 ||| IN
N-nitrosation ||| S:741 E:754 ||| NNP
,  ||| S:754 E:756 ||| ,
they  ||| S:756 E:761 ||| PRP
may  ||| S:761 E:765 ||| MD
contain  ||| S:765 E:773 ||| VB
secondary  ||| S:773 E:783 ||| JJ
amines  ||| S:783 E:790 ||| NN
as  ||| S:790 E:793 ||| IN
impurities  ||| S:793 E:804 ||| NN
in  ||| S:804 E:807 ||| IN
finished  ||| S:807 E:816 ||| JJ
products  ||| S:816 E:825 ||| NNS
that  ||| S:825 E:830 ||| WDT
may  ||| S:830 E:834 ||| MD
undergo  ||| S:834 E:842 ||| VB
N-nitrosation ||| S:842 E:855 ||| JJ
.  ||| S:855 E:857 ||| .
These  ||| S:857 E:863 ||| DT
ingredients  ||| S:863 E:875 ||| NNS
should  ||| S:875 E:882 ||| MD
not  ||| S:882 E:886 ||| RB
be  ||| S:886 E:889 ||| VB
included  ||| S:889 E:898 ||| VBN
in  ||| S:898 E:901 ||| IN
cosmetic  ||| S:901 E:910 ||| JJ
formulations  ||| S:910 E:923 ||| NNS
containing  ||| S:923 E:934 ||| VBG
N-nitrosating  ||| S:934 E:948 ||| JJ
agents ||| S:948 E:954 ||| NNS
.  ||| S:954 E:956 ||| .
The  ||| S:956 E:960 ||| DT
Cosmetic  ||| S:960 E:969 ||| NNP
Ingredient  ||| S:969 E:980 ||| NNP
Review  ||| S:980 E:987 ||| NNP
Expert  ||| S:987 E:994 ||| NNP
Panel  ||| S:994 E:1000 ||| NNP
concludes  ||| S:1000 E:1010 ||| VBZ
that  ||| S:1010 E:1015 ||| DT
aminomethyl  ||| S:1015 E:1027 ||| JJ
propanol  ||| S:1027 E:1036 ||| NN
and  ||| S:1036 E:1040 ||| CC
aminomethyl  ||| S:1040 E:1052 ||| JJ
propanediol  ||| S:1052 E:1064 ||| NNS
are  ||| S:1064 E:1068 ||| VBP
safe  ||| S:1068 E:1073 ||| JJ
as  ||| S:1073 E:1076 ||| IN
cosmetic  ||| S:1076 E:1085 ||| JJ
ingredients  ||| S:1085 E:1097 ||| NNS
in  ||| S:1097 E:1100 ||| IN
the  ||| S:1100 E:1104 ||| DT
practices  ||| S:1104 E:1114 ||| NNS
of  ||| S:1114 E:1117 ||| IN
use  ||| S:1117 E:1121 ||| NN
and  ||| S:1121 E:1125 ||| CC
concentrations  ||| S:1125 E:1140 ||| NNS
as  ||| S:1140 E:1143 ||| RB
described  ||| S:1143 E:1153 ||| VBN
in  ||| S:1153 E:1156 ||| IN
this  ||| S:1156 E:1161 ||| DT
safety  ||| S:1161 E:1168 ||| NN
assessment ||| S:1168 E:1178 ||| NN
.  ||| S:1178 E:1180 ||| .
